Gilead Sciences, Inc.GILDNASDAQ
Loading
P/E Ratio: Discounted ValuationCompressed
Percentile Rank57
3Y CAGR-8.6%
5Y CAGR-50.4%
Year-over-Year Change
Price-to-earnings ratio
3Y CAGR
-8.6%/yr
vs +12.1%/yr prior
5Y CAGR
-50.4%/yr
Recent acceleration
Acceleration
-20.6pp
Decelerating
Percentile
P57
Within normal range
vs 5Y Ago
0x
Contraction
Streak
1 yr
Consecutive declineCompressed
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 17.94 | -92.5% |
| 2024 | 239.97 | +1244.6% |
| 2023 | 17.85 | -23.9% |
| 2022 | 23.46 | +60.2% |
| 2021 | 14.65 | -97.5% |
| 2020 | 595.39 | +3785.8% |
| 2019 | 15.32 | +2.9% |
| 2018 | 14.88 | -26.4% |
| 2017 | 20.23 | +184.9% |
| 2016 | 7.10 | - |